Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 601 - 650 out of 6,401

Document Document Title
WO/2007/070820
A method of preparing the anthracyclin carminomycin using a starting material comprising daunorubicin. The method comprises reacting daunorubicin or N-protected daunorubicin with soft Lewis acids for the demethylation of the 4-methoxy gr...  
WO/2007/068745
The invention concerns novel polyunsaturated compounds of formula (I) wherein: R1 represents a R'1, -A-R'1 group, R'1 being selected among - COOH, -COOR3, -CONH2, -CONHR3, -CONR3 R4, -CHO, -CH2OH, -CH2OR5, and A represents a C2-C16 alkyl...  
WO/2007/066805
According to the invention, a compound represented by the formula (I) (wherein A represents an aryl group or a monocyclic or dicyclic heterocyclic group, R1 represents a halide, a nitro group, a substituted C1-6 alkyl group, an amino gro...  
WO/2007/064954
The present invention is directed to analogs of aminoglycoside compounds as well as their preparation and use as prophylactic or therapeutics against microbial infection.  
WO/2007/064954
The present invention is directed to analogs of aminoglycoside compounds as well as their preparation and use as prophylactic or therapeutics against microbial infection.  
WO/2007/063356
The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds of this invention can be useful for inhibition and prevention of inflammation and associated pathologies, including inflammatory and a...  
WO/2007/063356
The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds of this invention can be useful for inhibition and prevention of inflammation and associated pathologies, including inflammatory and a...  
WO/2007/061796
The present invention relates generally to pharmaceutical compositions comprising non-caloric or low-caloric high-potency sweeteners and methods for making and using them, in particular, the present invention relates to different pharmac...  
WO/2007/061796
The present invention relates generally to pharmaceutical compositions comprising non-caloric or low-caloric high-potency sweeteners and methods for making and using them, in particular, the present invention relates to different pharmac...  
WO/2007/056525
The invention relates to high affinity Siglec ligands that are useful for isolating cells that express Siglecs and for delivering agents to cells that express Siglecs. In one embodiment, the invention provides a method for treating cance...  
WO/2007/054977
The present invention relates to a compound of formula I: [(C)-(L')]n-(A)-[(L)-(B)]mwherein (A) is a thioglycosylated cysteine of formula IIa or IIb: IIa IIb; (B) is a melanogenosis-inhibiting peptide comprising peptide sequence selected...  
WO/2007/049819
Disclosed is a therapeutic agent for a disease in which an NKT cell or the stimulation of an NKT cell is involved in the aggravation of a morbid condition thereof. The therapeutic agent comprises a chemically synthesized glycolipid deriv...  
WO/2007/050668
There are disclosed compound of formula I, in which R1 represents a hydrophobic moiety adapted to occupy the C’ channel of human CDId, R2 represents a hydrophobic moiety adapted to occupy the A' channel of human CDId, such that R1 fill...  
WO/2007/048974
The invention concerns novel glycoside oligomers, monomers useful for preparing same, as well as a method for preparing such oligomers and in particular D-glucosamine and N-acétyl-D-glucosamine heterooligomers, enabling the size, the de...  
WO/2007/048974
The invention concerns novel glycoside oligomers, monomers useful for preparing same, as well as a method for preparing such oligomers and in particular D-glucosamine and N-acétyl-D-glucosamine heterooligomers, enabling the size, the de...  
WO/2007/045469
The present invention relates to new adjuvants and the uses in pharmaceutical compositions, like in vaccines. In particular, the present invention provides new compounds useful as adjuvants for prophylactic and/or therapeutic vaccination...  
WO/2007/042469
The present invention relates compounds of the formula: oligosaccharide-spacer-(GpIIb/IIIa antagonist), wherein the oligosaccharide is a negatively charged oligosaccharide residue comprising four to twenty five monosaccharide units, the ...  
WO/2007/042470
The present invention relates compounds of the formula I : oligosaccharide-spacer-GpIIb/IIIa antagonist I, wherein the oligosaccharide is a negatively charged pentasaccharide residue of the structure (I), the charge being compensated by ...  
WO/2007/042469
The present invention relates compounds of the formula: oligosaccharide-spacer-(GpIIb/IIIa antagonist), wherein the oligosaccharide is a negatively charged oligosaccharide residue comprising four to twenty five monosaccharide units, the ...  
WO/2007/041514
A process is described for selectively extracting cocoa procyanidins from an aqueous mixture of cocoa polyphenols by using a particular sequence of solvents to extract selected procyanidin monomers and/or oligomers. The solvents are n-bu...  
WO/2007/038829
The invention provides a method of identifying biologically active compounds comprising: (a) designing a first library of compounds of formula (1) to scan molecular diversity wherein each compound of the library has at least two pharmaco...  
WO/2007/033292
Compositions that include combinations of agents that inhibit carbohydrate degradation, decrease formation or severity of intestinal gas, and/or modulate insulin signalling or blood glucose levels are described. Methods of administering ...  
WO/2007/028812
The invention relates to the CGRP antagonists of general formula (I) in which R1, R2 and R3 have the definitions given in claim 1, the tautomers, isomers, diastereomers, enantiomers, anomers, hydrates, mixtures, salts, and the hydrates o...  
WO/2007/028812
The invention relates to the CGRP antagonists of general formula (I) in which R1, R2 and R3 have the definitions given in claim 1, the tautomers, isomers, diastereomers, enantiomers, anomers, hydrates, mixtures, salts, and the hydrates o...  
WO/2007/026675
Discloses is a process for producing α-D-glucopyranose, 3-O-decyl-2-deoxy-6-O-[2-deoxy-3-O-[(3R)-3-methoxydecyl]-6-O -methyl-2-[(11Z)-1-oxo-11-octadecenyl]amino]-4-O-phosphono- -D-glucopyranosyl]-2-[(1,3-dioxotetradecyl)amino]- or 1-(...  
WO/2007/028012
The present invention is directed to analogs of aminoglycoside compounds as well as their preparation and use as prophylactic or therapeutics against microbial infection.  
WO/2007/028012
The present invention is directed to analogs of aminoglycoside compounds as well as their preparation and use as prophylactic or therapeutics against microbial infection.  
WO/2007/028050
Compounds and methods are provided for modulating in vitro and in vivo processes mediated by selectin binding. More specifically, selectin modulators and their use are described, wherein the selectin modulators that modulate (e.g., inhib...  
WO/2007/023583
To synthesize a glycolipid derivative typified by GGPL-III, it is required to efficiently synthesize an intermediate in synthesizing the glycolipid derivative represented by the general formula (VIII). For this purpose, it is needed to c...  
WO/2007/020795
Gallic acid derivatives represented by the general formula (1): [wherein R1 is hydrogen, alkali metal, alkaline earth metal, transition metal, substituted or unsubstituted ammonium, or alkyl or alkenyl having 1 to 22 carbon atoms; and R2...  
WO/2007/021900
Disclosed are compositions for the treatment of anorectal disorders comprising at least one analgesic, at least one anti-inflammatory agent, antibiotic, and optionally but preferably hyaluronic acid, in amounts and under conditions effec...  
WO/2007/014894
Glucopyranosyl-substituted ((hetero)cycloalkylethynyl-benzyl)-benzene derivatives of the general Formula (I) where the groups R1 to R6 as well as R7a, R7b, R7c are defined according to claim 1, including the tautomers, the stereoisomers ...  
WO/2007/014894
Glucopyranosyl-substituted ((hetero)cycloalkylethynyl-benzyl)-benzene derivatives of the general Formula (I) where the groups R1 to R6 as well as R7a, R7b, R7c are defined according to claim 1, including the tautomers, the stereoisomers ...  
WO/2007/016455
Disclosed are compositions and methods related to aminoglycoside dimers aminoglycoside conjugates, and their uses.  
WO/2007/013522
[PROBLEMS] To provide a process for producing a glycolipid-containing Simon potato extract or a glycosphingolipid from a Simon potato for the purpose of providing an alternative to a livestock brain ganglioside which is free from the ris...  
WO/2007/009637
The invention relates to the objects which are characterised in the patent claims, that is, metal complexes which contain perfluoroalkyl having N-alkyl groups of general formula (I), to a method for the production thereof and to the use ...  
WO/2007/009772
The present invention relates to 3-demethoxy-3-aminothiocolchicine glycosyl derivatives of general formula (I) in which R is hydrogen, methyl or hydroxymethyl. The compounds of formula (I) have myorelaxant and anti-inflammatory activity.  
WO/2007/009637
The invention relates to the objects which are characterised in the patent claims, that is, metal complexes which contain perfluoroalkyl having N-alkyl groups of general formula (I), to a method for the production thereof and to the use ...  
WO/2007/006152
A buckwheat extract comprising at least myo-inositol, D-chiro-inositol, a fagopyritol, one MAPK-stimulating compound, and one glucose-uptake inhibiting compound. A substantially pure glucose-uptake inhibiting compound selected from a buc...  
WO/2007/004705
A glycolipid derivative represented by the formula (I): (I) wherein R1 represents an aldopyranaose residue, R2 represents a hydrogen atom or a hydroxyl group, A represents -CH2-,-CH(OH)-CH2- or -CH=CHCH2-, Z represents -O- or -CH2-, and ...  
WO/2007/003236
The method according to the invention comprises using as glycosyl donors high purity 2- deoxy-2-iodo derivatives of sugars of a defined configuration of C-2 carbon with O-alkyl, S- alkyl, O-aryl, S-aryl, O-heteroaryl, S-heteroaryl, O-acy...  
WO/2007/000967
A remedy for cerebral infarction which contains glycyrrhizin and/or a pharmaceutically acceptable salt thereof as the active ingredient. As the pharmaceutically acceptable salt, use may be appropriately made of glycyrrhizin ammonium salt...  
WO/2006/136933
A composition for the treatment and/or prevention of attacks by biological agents characterised in that it comprises at least: a modulator means; a by-product of Brassicaceae seeds; water.  
WO/2006/136933
A composition for the treatment and/or prevention of attacks by biological agents characterised in that it comprises at least: a modulator means; a by-product of Brassicaceae seeds; water.  
WO/2006/136429
The present invention relates to compounds of the formula (I); wherein R1 Js H, CH3 or OCH3; R3 = H, OH, CH3, OCH3, O-glucose or benzoyloxy; R4 = H; R5 = H or OH; R6 = H or OCH3; R7 = H, CH3, OCH3, cinnamoyloxy or (3,4,5-trimethoxy)-benz...  
WO/2006/134352
The present invention relates to methods of preparing anthocyanins, and methods of preparing precursors of anthocyanins. The methods utilise a coupling reaction between a sugar and a suitable electrophilic precursor to form Eastern half ...  
WO/2006/135083
Disclosed are a pharmaceutical for the prevention or treatment of visceral fat syndrome and a beverage/food for the prevention or amelioration of the disease. A prophylactic or therapeutic agent for visceral fat syndrome comprising luteo...  
WO/2006/135084
Disclosed are a pharmaceutical for the prevention or treatment of steatohepatitis, particularly non-alcoholic steatohepatitis or fatty liver and a beverage/food for the prevention or amelioration of the disease. A prophylactic or therape...  
WO/2006/133447
Described are novel crystalline pivaloyl furanoses and methods of crystallizing the pivaloyl furanoses. These compounds are useful as intermediates in the synthesis of compounds such as the deoxyjirimycins and nojirimycins and are partic...  
WO/2006/128738
The invention relates to a composition for depigmenting the skin comprising a compound of formula (I) : in which: - S represents a monosaccharide or a polysaccharide containing up to 20 sugar units; - the bond S-CH2 being a C-glycoside b...  

Matches 601 - 650 out of 6,401